ADENOSINE
- Product NDC
- 51662-1511
- 11-digit product format
- 516621511
- Labeler code
- 51662
- Product ID
- 51662-1511_b98519b2-197f-5a71-e053-2995a90ab79a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ADENOSINE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA077283
- Marketing category
- ANDA
- Marketing start
- 2021-01-21
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ADENOSINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ADENOSINE | 3 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K72T3FS567 |
| Rxcui | 727355 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1511-1 | ADENOSINE | 1 in 1 CARTON | INJECTION | 1 | | 2 |
| 51662-1511-1 | ADENOSINE | 4 mL in 1 SYRINGE | INJECTION | 4 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1511 | ADENOSINE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 2 | Current NDC, Legacy NDC, 2 package rows | 20210127_b973bce7-0500-63a2-e053-2a95a90af9e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1511-1 | 51662151101 | 1 SYRINGE in 1 CARTON (51662-1511-1) / 4 mL in 1 SYRINGE | 1 syringe | 2021-01-21 | 0000-00-00 | No | No | Current |